Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment.
Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, Patel S, Patel A, Patel V, Patel B.
Shah U, et al. Among authors: patel v, patel m, patel a, patel b, patel s.
CNS Neurol Disord Drug Targets. 2023;22(10):1462-1471. doi: 10.2174/1871527322666221005124808.
CNS Neurol Disord Drug Targets. 2023.
PMID: 36200162
Review.